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D94929 PredictiveValueof ExercieeTestingfortheDetectionof Isolatedor Non-isolatedLeftMain
CoronaryArteryStenosis
C.C. de Cock, J. Paats, J.G.F. Bronzwaer, CA. Visser. Free University
Hospital, Amsterdam, The Netherlands
To evaluate exercise test results and coronaq! anatomy in patients referred
for the evaluation of chest pain, we reviewed the coronary angiograms and
exercise tests (Bruce protocol) of 2813 consecutive patients. All patients un-
derwent symptom limited exercise testing two days prior to cardiac catheteri-
zation. Left main coronary stenosis (LMCS) was present in 121patients (pts):
34 had isolated LMCS (group 1), while 87 had concomitant coronaw artery
disease (group 2). Matched control pts with 3-vessel disease (group 3) had
significantly iesa exertional hypotension i.e. <20 mmHg increase in systolic
biood pressure (12Yo)compared to group 1 (22%) and group 2 (24%, p <
0.01), ionger exercise duration (8.5+ 1.4 rein) compared to group 1 (4.4+
1.2 rein, p < 0.001) and group 2 (4.1 & 1.1 rein, p < 0.001) and less exercise
induced atrial arrhythmias (3.1%) compared to group 1 (8.OYO,p c 0.001).
In addition, termination of the test because of signs of cerebral hypoper-
fusion (pre-syneope or dizzyness) was present in 3% in group 1 and 5% in
group 3, p = ns, compared to 18% in group 2 (p < 0.001). From eisctrocar-
diographic abnormalities, only one (ST-segment depression ?1 mm in 57
leads including ST-segment elevation in V2) was different in pts with LMCS
(18% in group 1, 22% in group 2) compared to pts in group 3, (l%, p c
0.001). Multivariate analysia revealad that signs of cerebral hypoperfusion,
exertional hypotension and atrial arrhythmias were the 3 independent pre-
dictor of LCMS; clinical signs of cerebral hypoperfusion is suggestive for
LMCS in addition to conmmitant coronary arte~ disease.
PI CostEffectivenessAnalYsisofStressMYo~ardial
PerfusionImaginginStableAnginaPatients:
InfluenceofAgeandPreteetRiskof Coronary
Disease
L.J. Shaw, R. Hachamovitch, T.H. Marwick, G.V. Heller, D.S. Berman,
S. Borges-Neto, Ml. Travin, M.S. Lauer, D.D. Miller, for the Economics of
Noninvasive Diagnosis Multicenter Study Group. Duke University Durham,
NC
Cost effaetiveness analysis (CEA) evaluates the outcomes and costs of in-
terventions designed to improve health. Cost effectiveness data for stress
myoeardial imaging in 9,791 stable angina patients (35% female, 42% rs-
veraible defects) enrolled from 7 hospitals (annual cardiac death rate =0.9%
over 2.5 & 1.5 years) was obtained from each hospital using a top-down
coeting approach, adjusting Medicare charges by coat-charge ratios + Msdi-
care fee schedule for physician costs. CEA = ACost/Alife expectancy from
United States population-based tables (cost discount rate = 5%). The table
below indicates CEA for clinically low (S 15%), intermediate (18-60%), and
high (> 60%) risk patients (reference case age= 80 years).
PretestCsrdiacRisk(n) AnnualCardiacDeath CEA
All Elderly
Low(S26) 0.6”A $254s209 $34,650
intermediate(3,3SS) 1.6”/0 $2S,SS7 $23,310
High (1,607) 4,4”h $52,960 $42,737
In classifying CEA by age deciles, a standardized CEA threshold of
<$50,000 was achieved for low and high risk patients aged 2-70years.
Conclusion.’Use of stress myocardial perfusion imaging is most cost ef-
fective in intermediate risk patients who present with stable angina symptoms
or for those who are elderly.
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m950155 Clinical,EchocardiographicandExercisePredictorsof Outcomeina ProspectiveStudyof
ValvularAotticStenosis
C.M. Otto, LG. Burwash, M.E. Legget, B.1.Munt, N.L. Healy. Urriversifyof
Washington, Seattle, WA, USA
In 123 adults (mean age 83 + 18 years) with asymptomatic aortic stenosis
(AS), annual clinical, echocardiographic and exercise data were obtained
prospectively over a mean follow-up of 2.5 + 1.4 (range 0.3 to 8.3) yrs.
AS-jet velocity (Vma) changed by 0.32+ 0.34 m/s/yr, mean gradient (AP) by
7 l7 mmH@yrand valve area (AVA)by -0.12 + 0.19 cm2/yr. Kaplan Meier
event-free survival, with endpointe defined as death (n = 8) or aortic valve
replacement (AVR) (n = 48), was 93 +5% at 1 year, 62 +6% at 3 yeare and
26+ 10% at 5 years.
Univariate predictors of AVR or daath included baseline V~U (3.9 + 0.5
vs 3.3 + 0.5 mfs, p < 0.001), mean AP (38 + 12 vs 25 + 8 mmHg, p <
0.001), AVA (1.11 + 0.34 vs 1.53 + 0.53 cmz, p < 0.001), and the rate of
increase in V~m (0.45+ 0.42 vs 0.23 + 0.22 rn/a/yr p = 0.001), but not age,
gender or etiology of AS. Those with an endpoint had a smaller exercise
increase in AVA(0.05 & 0.28 vs 0.27 + 0.38 cm2, p = 0.001), blood pressure
(15 + 7 vs 29 + 20 mmHg) and cardiac output (5.9 +4.2 vs 8.5 + 4.7, p =
0.004), and a greater exercise decrease in stroke volume (-12 + 20 vs –2
+23 ml, p = 0.03).
On Cox regression analysis, multivariate predictors of clinical outcome
were V-at baseline (p < 0.0001), the rate of change in VmaX(p < 0.0001)
and functional status score (p = 0.002), For those with VmaX>4.0 m/s, the
likelihood of remaining alive without AVR at 2 years was only 21 + 18%,
compared to 66 + 13% for a V~~ of 3.0-4.0 rris and 64 & 160/.for a Vma,
<3.0 m/s (p<0.0001).
These data will be helpful in management and foliow-up of adults with
asymptomatic AS and will be useful in designing future trials of interventions
to slow disease progression.
1950-1561FIO~-Dependen~eOfAotticStenosisSeverity:
Comparisonofthe GorlinsndContinuity
EquationswithDirectPlanimetryofthe
AnatomicalOrificeduringTraneesophageal
Echocardiography
J.-L. Vanoverschelde, A. Pasquet, A.-M. D’Hondt, M. De Kock. University of
Louvain, Brussels, Belgium
Increase in aortic valve area (AVA) with increasing flow rates is common
when using the Gorlin and the continuity equations for AVA calculation.
To test whether these changes reflect true increases in anatomical area
or inaccuracies in calculation methods, right heart hemodynamics (7 Fr
Swan Ganz), cardiac output (thermodilution), transaortic flow velocity (CW
Doppler) and direct planimetry of the anatomical orifice (TEE) were obtained
simultaneously in’7 patients with isolated aortic stenosis (AVA: 0.63 + 0.14
cm2),at baseline and during infusion of 10 @/kg/rein of dobutamine. Infusion
of dobutamine resulted in significant increases in heart rate (from 81 + 12 to
91 +22 bpm), cardiac output (from 3.4+ 1.9 to 5.3 & 2.7 Umin), transaortic
flow rates (159 * 36t0249 + 45 mUs) and mean pressure gradient (from 33
+ 17 to 50 + 28 mmHg). As axpected, AVAScalculated with both the Goriin
(+29%, from 0.65 + 0.14 to 0.84 + 0.16 cmz, p < 0.02) and the continuity
(+30%, from O.&l + 0.13 to 0.76 + 0.17 cm2, p < 0.03) equations increased
with increasing flow rates. No significant changes were noted, however, in
AVA measured by planimetry (from 0.63+ 0.22 to 0.81 + 0.23 cmz, p = ns).
At low flow rates, TEE AVA correlated weakly with that calculated with the
Gorlin (r= 0.56) or the continuity (r= 0.56) equations. Correlations improved
at high flow rates (r = 0.77 and 0.79, respectively). Thus, the data indicate
that AVAScalculated with the Gorlin and the continuity equations increase
with flow rates, while true anatomical orifice area does not. As calculated
AVASunderestimate the true anatomical area at low flow rates, their flow-
dependence probably reflects flow-dependent changes in the coefficient of
orifice contraction.
I-I ChangeslnCoronaryBloodFlowkt”RelstionTo
ChangesInHemodynamicParametersDuring
BetsBlockadeIn PatientsWithAorticValve
Stenosis
M. Kyriakidis, J. Dernellis, A. Trikas, J. Barbetseas, C. Tentolouris,
A.,Anastasakis, J. Giaiafos, P.Toutouzas. Department of Cardiology,
f-fippokrationf-fospifa/,University of Athens, Greece
AIterations in coronary flow velocity (CFV) have been demonstrated at rest
in patients with aortic valve stenoais (AVS) but have never been etudiad
after beta-adrenoreceptor blocker administration. Twenty-three patients with
significant pure AVS (14 with exertional symptoms [group 1], 9 asymptomatic
[group 2] and 8 control subjects [group 3], all with normal coronary arteries,
were studied successively at rest, after esmolol infusion (bolus dose of 500
&/kg/min and by continuous infusion of 50 @kg/rein) and after atropine
administration (0.025 to 0.040 mg/kg) by proximal left anterior descending
(IAD) intracoronary Doppierflowvelocimetry concomitant with hemodynamic
measurements. In all patients, cardiac index increased after atropine but
it decfeaaed after esmolol. Svstolic retrograde CFV was recorded onlv in
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